Identification Properties Safety Data Specifications and Other Information Links Identification CAS Number 56124-62-0
Name Valrubicin
Synonyms (2S-cis)-Pentanoic Acid 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-a-L-lyxo-hexopyranosyl)oxy)-2-naphthacenyl)-2-oxoethyl Ester 2-Oxo-2-[(
2S ,
4S )-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydro-2-tetracenyl]ethyl valerate [
ACD /
IUPAC Name] 2-oxo-2-[(
2S ,
4S )-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate 2-Oxo-2-[(
2S ,
4S )-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl valerate 2-Oxo-2-[(
2S ,
4S )-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-tridesoxy-3-[(trifluoracetyl)amino]-α-L-lyxo-hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydro-2-tetracenyl]ethylvalerat [German] [
ACD /
IUPAC Name] 56124-62-0 [
RN ] N-Trifluoroacetyladriamycin 14-valerate N-Trifluoroacetyldoxorubicin 14-valerate Pentanoic acid, 2-[(
2S ,
4S )-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester [
ACD /Index Name] pentanoic acid, 2-[(
2S ,
4S )-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester Valérate de 2-oxo-2-[(
2S ,
4S )-2,5,12-trihydroxy-7-méthoxy-6,11-dioxo-4-({2,3,6-tridésoxy-3-[(2,2,2-trifluoroacétyl)amino]-α-L-lyxo-hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydro-2-tétracényl]éthyle [French] [
ACD /
IUPAC Name] Valrubicin [
INN ] [
USP ] [Wiki] valrubicina [Spanish] [
INN ] valrubicine [French] [
INN ] valrubicinum [Latin] [
INN ] Valstar [Trade name] (2S-cis)-Pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-α-L-lyxo-hexopyranosyl)oxy)-2-naphthacenyl)-2-oxoethyl ester [2-oxo-2-[(
2S ,
4S )-2,5,12-trihydroxy-4-[(
2R ,
4S ,
5S ,
6S )-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate [2-oxo-2-[(
2S ,
4S )-2,5,12-trihydroxy-4-[(
2R ,
4S ,
5S ,
6S )-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydropyran-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate [2-Oxo-2-[(
2S ,
4S )-2,5,12-trihydroxy-4-[5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl]pentanoate [56124-62-0] 2-oxo-2-[(
2S ,
4S )-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate
AD32 Antibiotic
AD 32
MFCD01939322 N-Trifluoroacetyladriamycin-14-valerate
UNII-2C6NUM6878 Valtaxin
Molecular Structure SMILES CCCCC (=O)
OCC (=O)[C@@]1(Cc2c(c(c3c(c2O)C(=O)c4cccc(c4C3=O)
OC )O)[C@H](
C1 )O[C@H]
5C [C@@H]([C@@H]([C@@H](
O5 )C)O)
NC (=O)C(F)(F)F)O
StdInChI InChI=
1S /
C34H36F3NO13 /c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,
47H ,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1
StdInChIKey ZOCKGBMQLCSHFP-KQRAQHLDSA-N Molecular Formula C34H36F3NO13 Molecular Weight 723.64
Properties Appearance White powder
Specifications and Other Information of Our Valrubicin CAS 56124-62-0 Standard Enterprise standard
Identification Methods HNMR /
HPLC Purity 98%min
Storage Under the room temperature and away from light
Application Used as the pharmaceutical
API Links This product is developed by our RandD company Caming Pharmaceutical Ltd(
http://www.caming.com/ ), and here is the corresponding link
http://www.caming.com/valrubicin-cas-56124-62-0/ Quick Inquiry Fill out our inquiry form and one of our experts will be in touch with you shortly (Please change screen to horizontal for complete browsing if you are checking Watson on your mobile phone).
andD purpose. It may be toxic or hazardous, and should be handled only by qualified individuals trained in laboratory procedures. The buyer will be responsible to warn and inform any person that may be in contact with the product of the potential risks and hazards, as well as to ensure that purchase, use and disposal of the product comply with local laws and regulations.